Skip to content
MedsAcross

Molecule

5-aminolevulinic acid

Presentations
0
Brands
0
Manufacturers
0
Available from stock
0

5-aminolevulinic acid is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

ATC classification
L01XD04 Aminolevulinic acid · Cancer medicines (antineoplastics), subgroup L01X, subgroup L01XD
US FDA first approval
Not recorded
EU status
Authorised
Orphan designation
No
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Identifiers
UNII 88755TAZ87RxCUI 683CAS 106-60-5DrugBank DB00855Q238474

All presentations

No presentations of 5-aminolevulinic acid are listed yet. Ask us to source it

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDANot recorded—
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026

Conditions

Conditions linked to 5-aminolevulinic acid in public data. This is not a list of approved uses, see the clinical information.

Questions and answers

Is 5-aminolevulinic acid available for export from India?

No presentation of 5-aminolevulinic acid is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.

Is 5-aminolevulinic acid authorised in the European Union?

Yes. 5-aminolevulinic acid has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.

Does 5-aminolevulinic acid need cold chain shipping?

No listed presentation of 5-aminolevulinic acid is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is 5-aminolevulinic acid in?

5-aminolevulinic acid is classified under ATC code L01XD04 (Aminolevulinic acid).

References

  1. Ameluz: European public assessment report (EPAR). European Medicines Agency. Retrieved 3 June 2026
  2. Gliolan: European public assessment report (EPAR). European Medicines Agency. Retrieved 30 October 2024

Request 5-aminolevulinic acid for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.